WO2005046649A3 - Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz - Google Patents
Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz Download PDFInfo
- Publication number
- WO2005046649A3 WO2005046649A3 PCT/EP2004/010297 EP2004010297W WO2005046649A3 WO 2005046649 A3 WO2005046649 A3 WO 2005046649A3 EP 2004010297 W EP2004010297 W EP 2004010297W WO 2005046649 A3 WO2005046649 A3 WO 2005046649A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substance
- acts
- release
- optionally
- active substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2007010611A MX2007010611A (es) | 2003-11-13 | 2004-09-15 | Forma farmaceutica multiparticulada que comprende microesferas con una matriz que tiene influencia en la entrega de una sustancia moduladora. |
PL04765211T PL1684729T3 (pl) | 2003-11-13 | 2004-09-15 | Wielowarstwowa postać leku, zawierająca substancję działającą modulująco co do uwalniania substancji czynnej |
US10/572,963 US20060269605A1 (en) | 2003-11-13 | 2004-09-15 | Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances |
BRPI0416501-2A BRPI0416501A (pt) | 2003-11-13 | 2004-09-15 | forma de dosagem farmacêutica com múltiplas camadas contendo uma substáncia que age de uma forma modulatória, no que diz respeito á liberação das substáncias ativas |
DE502004007172T DE502004007172D1 (de) | 2003-11-13 | 2004-09-15 | Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz |
SI200430816T SI1684729T1 (sl) | 2003-11-13 | 2004-09-15 | Večplastna farmacevtska oblika, ki vsebuje snov,ki ima modulacijski učinek glede na sproščanjeučinkovine |
JP2006538671A JP2007510676A (ja) | 2003-11-13 | 2004-09-15 | 作用物質放出に関して調節作用のある物質を含有する、多層の剤形 |
CA002544497A CA2544497A1 (en) | 2003-11-13 | 2004-09-15 | Multilayer pharmaceutical form comprising a substance having a modular effect in relation to active ingredient release |
EP04765211A EP1684729B1 (de) | 2003-11-13 | 2004-09-15 | Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz |
IL175561A IL175561A0 (en) | 2003-11-13 | 2006-05-11 | Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10353186A DE10353186A1 (de) | 2003-11-13 | 2003-11-13 | Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz |
DE10353186.6 | 2003-11-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005046649A2 WO2005046649A2 (de) | 2005-05-26 |
WO2005046649A3 true WO2005046649A3 (de) | 2005-10-27 |
Family
ID=34585088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/010297 WO2005046649A2 (de) | 2003-11-13 | 2004-09-15 | Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz |
Country Status (15)
Country | Link |
---|---|
US (1) | US20060269605A1 (de) |
EP (1) | EP1684729B1 (de) |
JP (1) | JP2007510676A (de) |
KR (1) | KR20060121182A (de) |
CN (1) | CN1863515A (de) |
AT (1) | ATE395046T1 (de) |
BR (1) | BRPI0416501A (de) |
CA (1) | CA2544497A1 (de) |
DE (2) | DE10353186A1 (de) |
ES (1) | ES2307044T3 (de) |
IL (1) | IL175561A0 (de) |
MX (1) | MX2007010611A (de) |
PL (1) | PL1684729T3 (de) |
SI (1) | SI1684729T1 (de) |
WO (1) | WO2005046649A2 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS50407B (sr) | 2000-02-08 | 2009-12-31 | Euro-Celtique S.A., | Oralne formulacije opijatnog agonista otporne na mehaničke,termičke i/ili hemijske promene fizičkih osobina doznog oblika |
PT1551372T (pt) | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | Subunidade de sequestração e composições e métodos relacionados |
DE10250543A1 (de) * | 2002-10-29 | 2004-05-19 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
MY135852A (en) | 2003-04-21 | 2008-07-31 | Euro Celtique Sa | Pharmaceutical products |
DE102004036437A1 (de) | 2004-07-27 | 2006-03-23 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
DE102004059792A1 (de) * | 2004-12-10 | 2006-06-14 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
AU2005325930B2 (en) * | 2005-01-27 | 2012-01-19 | Alembic Limited | Extended release formulation of Levetiracetam |
DE102005007059A1 (de) | 2005-02-15 | 2006-08-24 | Röhm GmbH & Co. KG | Teilneutralisiertes anionisches (Meth)acrylat-Copolymer |
EP1863453A2 (de) * | 2005-03-29 | 2007-12-12 | Evonik Röhm GmbH | Multipartikuläre darreichungsform mit tabletten mit einer substanz mit modularer wirkung auf die wirkstofffreisetzung |
JP2008534531A (ja) * | 2005-03-29 | 2008-08-28 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 調節物質の送達に影響を及ぼすマトリックスを有するペレットを有する多粒子の医薬剤形 |
KR101413613B1 (ko) * | 2006-01-27 | 2014-07-10 | 앱탈리스 파마테크, 인코포레이티드 | 약 염기성 선택성 세로토닌 5-ht3 차단제와 유기산을 포함하는 약물 전달 시스템 |
US7829148B2 (en) * | 2006-02-07 | 2010-11-09 | Fmc Corporation | Coating process to produce controlled release coatings |
JP5649784B2 (ja) * | 2006-02-07 | 2015-01-07 | エフ エム シー コーポレーションFmc Corporation | 組成物、基材を組成物でコーティングする方法、被覆基材、製品、フィルム、ペレット、タブレット及びカプセル |
KR20080099334A (ko) * | 2006-02-24 | 2008-11-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | 메토프로롤 숙시네이트 서방정 및 이의 제조 방법 |
EP2526932B1 (de) | 2006-06-19 | 2017-06-07 | Alpharma Pharmaceuticals LLC | Pharmazeutische Zusammensetzung |
DE102006035549A1 (de) * | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
US20080292695A1 (en) * | 2006-12-01 | 2008-11-27 | Kristin Arnold | Carvedilol forms, compositions, and methods of preparation thereof |
US20090028935A1 (en) * | 2006-12-01 | 2009-01-29 | Kristin Arnold | Carvedilol forms, compositions, and methods of preparation thereof |
JP5228359B2 (ja) * | 2007-04-12 | 2013-07-03 | ニプロ株式会社 | 主薬粒子及びその製造方法ならびに口腔内崩壊錠 |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
JP2011509265A (ja) * | 2008-01-10 | 2011-03-24 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 活性物質のパルス放出が強化された、コーティングされた医薬製剤もしくはニュートラシューティカル製剤 |
KR20100103565A (ko) * | 2008-01-10 | 2010-09-27 | 에보니크 룀 게엠베하 | 촉진되고 조절된 활성 물질 방출을 갖는 코팅된 제약학적 또는 건강기능성 제제 |
CN101877971A (zh) * | 2008-01-10 | 2010-11-03 | 赢创罗姆有限公司 | 具有活性物质在结肠中增强的释放的包衣药物或营养制剂 |
TWI519322B (zh) * | 2008-04-15 | 2016-02-01 | 愛戴爾製藥股份有限公司 | 包含弱鹼性藥物及控制釋放劑型之組合物 |
ES2602604T3 (es) * | 2008-11-18 | 2017-02-21 | Ucb Biopharma Sprl | Formulaciones de liberación prolongada que comprenden un derivado de 2-oxo-1-pirrolidina |
WO2011025673A1 (en) * | 2009-08-26 | 2011-03-03 | Aptapharma, Inc. | Multilayer minitablets |
CN102595894A (zh) * | 2009-08-27 | 2012-07-18 | 美国政府卫生与公众服务部 | 治疗疟疾和预防疟疾传播的化合物 |
EP2394644B1 (de) * | 2010-05-04 | 2014-07-09 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Trimetazidin-Formulierung mit unterschiedlichen Freisetzungsprofilen |
EP2585049A1 (de) | 2010-06-24 | 2013-05-01 | Merz Pharma GmbH & Co. KGaA | Darreichungsform von neramexan in mehreren einheiten |
US20140141090A1 (en) | 2011-02-02 | 2014-05-22 | Edward S. Wilson | Pharmaceutical Composition Comprising Opioid Agonist And Sequestered Antagonist |
JP5925188B2 (ja) * | 2011-04-08 | 2016-05-25 | ナノシータ株式会社 | 医薬製剤 |
US9446032B2 (en) * | 2011-08-26 | 2016-09-20 | Wockhardt Limited | Methods for treating cardiovascular disorders |
KR20140065862A (ko) * | 2012-11-22 | 2014-05-30 | 에스케이케미칼주식회사 | 발포성 속붕해성 이매티닙 제제 |
KR101451327B1 (ko) | 2013-01-08 | 2014-11-03 | 안국약품 주식회사 | 보센탄의 제어방출성 다층 정제 및 그 제조방법 |
KR102241487B1 (ko) | 2013-02-20 | 2021-04-16 | 주식회사 종근당 | 제어방출 펠릿으로 된 약제학적 조성물 |
CN103637999B (zh) * | 2013-12-12 | 2014-12-03 | 南通联亚药业有限公司 | 一种多层固体药物剂型 |
BR112017005574A2 (pt) | 2014-09-19 | 2017-12-12 | Procter & Gamble | formas de dosagem de liberação pulsada de fenilefrina |
TWI525110B (zh) * | 2014-12-24 | 2016-03-11 | 財團法人工業技術研究院 | 聚合物、及包含其之醫藥組合物 |
US10278930B2 (en) | 2017-03-16 | 2019-05-07 | The Procter & Gamble Company | Method for relieving sinus congestion |
NZ760393A (en) * | 2017-07-07 | 2022-07-29 | Dsm Ip Assets Bv | Compressed tablets |
ES2938609T3 (es) | 2017-09-20 | 2023-04-13 | Tillotts Pharma Ag | Preparación de formas farmacéuticas sólidas que comprenden anticuerpos mediante estratificación de solución/suspensión |
CN114159400A (zh) * | 2021-11-22 | 2022-03-11 | 山东省药学科学院 | 法匹拉韦包芯片 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19956486A1 (de) * | 1999-11-24 | 2001-06-21 | Lohmann Therapie Syst Lts | Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen |
US6322819B1 (en) * | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
EP1213015A1 (de) * | 1995-07-05 | 2002-06-12 | Byk Gulden Lomberg Chemische Fabrik GmbH | Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016992A (en) * | 1991-05-20 | 1992-12-30 | Marion Laboratories, Inc. | Multi-layered controlled release formulation |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
DE10149674A1 (de) * | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
DE10250543A1 (de) * | 2002-10-29 | 2004-05-19 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
-
2003
- 2003-11-13 DE DE10353186A patent/DE10353186A1/de not_active Withdrawn
-
2004
- 2004-09-15 PL PL04765211T patent/PL1684729T3/pl unknown
- 2004-09-15 MX MX2007010611A patent/MX2007010611A/es unknown
- 2004-09-15 WO PCT/EP2004/010297 patent/WO2005046649A2/de active IP Right Grant
- 2004-09-15 CN CNA2004800290437A patent/CN1863515A/zh active Pending
- 2004-09-15 JP JP2006538671A patent/JP2007510676A/ja active Pending
- 2004-09-15 US US10/572,963 patent/US20060269605A1/en not_active Abandoned
- 2004-09-15 ES ES04765211T patent/ES2307044T3/es active Active
- 2004-09-15 DE DE502004007172T patent/DE502004007172D1/de not_active Expired - Fee Related
- 2004-09-15 KR KR1020067011599A patent/KR20060121182A/ko not_active Application Discontinuation
- 2004-09-15 AT AT04765211T patent/ATE395046T1/de not_active IP Right Cessation
- 2004-09-15 CA CA002544497A patent/CA2544497A1/en not_active Abandoned
- 2004-09-15 BR BRPI0416501-2A patent/BRPI0416501A/pt not_active IP Right Cessation
- 2004-09-15 EP EP04765211A patent/EP1684729B1/de not_active Not-in-force
- 2004-09-15 SI SI200430816T patent/SI1684729T1/sl unknown
-
2006
- 2006-05-11 IL IL175561A patent/IL175561A0/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1213015A1 (de) * | 1995-07-05 | 2002-06-12 | Byk Gulden Lomberg Chemische Fabrik GmbH | Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern |
US6322819B1 (en) * | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
DE19956486A1 (de) * | 1999-11-24 | 2001-06-21 | Lohmann Therapie Syst Lts | Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen |
Also Published As
Publication number | Publication date |
---|---|
JP2007510676A (ja) | 2007-04-26 |
EP1684729B1 (de) | 2008-05-14 |
MX2007010611A (es) | 2009-02-19 |
SI1684729T1 (sl) | 2008-10-31 |
DE502004007172D1 (de) | 2008-06-26 |
DE10353186A1 (de) | 2005-06-16 |
PL1684729T3 (pl) | 2008-10-31 |
IL175561A0 (en) | 2006-09-05 |
ATE395046T1 (de) | 2008-05-15 |
BRPI0416501A (pt) | 2007-01-09 |
US20060269605A1 (en) | 2006-11-30 |
ES2307044T3 (es) | 2008-11-16 |
WO2005046649A2 (de) | 2005-05-26 |
KR20060121182A (ko) | 2006-11-28 |
EP1684729A2 (de) | 2006-08-02 |
CN1863515A (zh) | 2006-11-15 |
CA2544497A1 (en) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005046649A3 (de) | Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz | |
WO2005046561A3 (de) | Mehrschichtige arzneiform mit einer die abgabe einer modulatorischen substanz beeinflussenden matrix | |
WO2000019984A3 (de) | Überzogene arzneiformen mit kontrollierter wirkstoffabgabe | |
IL167334A (en) | Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers | |
WO2005079748A3 (en) | Pharmaceutical preparation for sustained release of a pharmaceutically active ingredient | |
ATE553754T1 (de) | Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser | |
CA2373909A1 (en) | Multilayer drug form release in the colon | |
WO2007006353A3 (de) | Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten | |
TW200635963A (en) | Partially neutralized anionic (meth)acrylate copolymer | |
WO2006102964A3 (en) | Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release | |
EP2153827A3 (de) | Zusammensetzung zur transdermalen Abgabe von Fentanyl | |
IL180849A0 (en) | Medicament in a multilayer form | |
MX356579B (es) | Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. | |
UA93530C2 (ru) | Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения | |
DK1195394T3 (da) | (Co-)polymerisater af hydroxyalkyl(meth)acrylater, fremgangsmåde til fremstilling heraf samt anvendelsen heraf i farmaceutiske indgivelsesformer | |
WO2002060417A8 (de) | Lagerstabiles haft- und bindemittel für pharmazeutische anwendungen | |
MX2010007578A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa. | |
MX2010007579A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada. | |
WO2009004649A3 (en) | Enteric coated pharmaceutical compositions | |
BG108668A (en) | Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480029043.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004765211 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006269605 Country of ref document: US Ref document number: 10572963 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2544497 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/005200 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 175561 Country of ref document: IL Ref document number: 1643/CHENP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006538671 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067011599 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004765211 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067011599 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10572963 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0416501 Country of ref document: BR |
|
WWG | Wipo information: grant in national office |
Ref document number: 2004765211 Country of ref document: EP |